The Journal of Immunology, Vol 142, Issue 1 252-256, Copyright © 1989 by American Association of Immunologists

ARTICLES

A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines [published erratum appears in J Immunol 1989 Jun 1;142(11):4118]

I Bourgault, A Gomez, E Gomard, F Picard, JP Levy and E] Gomrad E$[corrected to Gomard
Laboratoire d'Immunologie et Virologie des Tumeurs, Hopital Cochin, Paris, France.

Antiviral HLA class II-restricted cytotoxic CD4+ clones have been relatively well characterized in vitro but their significance in the immune response remains unknown. Here anti-influenza A and anti-EBV CD4+ CTL have been studied by using permanent cell lines either untreated or depleted of CD8+ cells. In bulk cultures, HLA class I- restricted anti-viral CD8+ CTL account for all of the detectable killer cell activity, whereas after elimination of CD8+ cells an HLA class II- restricted killer activity mediated by CD4+/2H4-/4B4+ cells was consistently observed. The CD4+ CTL were fully differentiated in all of the cultures tested from the third in vitro passage because they could be demonstrated immediately after elimination of CD8+ cells. These CD4+ killer cells were equivalent to the CD8+ cells in terms of their lytic capacity. The absence of any class II-restricted antiviral activity in bulk cultures seems to be related to the very small numbers of CD4+ cells present in these antiviral cell lines. However, CD4+ cytolytic activity could not be detected during the first two in vitro passages, even when limiting dilution analysis of the CTL precursors were performed, showing that the killer function of Th cells differentiate only after several in vitro stimulations.

This article has been cited by other articles:

				S. Mitra-Kaushik, J. Cruz, L. J. Stern, F. A. Ennis, and M. Terajima Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses J. Immunol., July 15, 2007; 179(2): 1303 - 1312. [Abstract] [Full Text] [PDF]

				N. R. Hegde, C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, and D. C. Johnson Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL J. Exp. Med., October 17, 2005; 202(8): 1109 - 1119. [Abstract] [Full Text] [PDF]

				E. R. Jellison, S.-K. Kim, and R. M. Welsh Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection J. Immunol., January 15, 2005; 174(2): 614 - 618. [Abstract] [Full Text] [PDF]

				M. Nakagawa, D. P. Stites, J. M. Palefsky, Z. Kneass, and A.-B. Moscicki CD4-Positive and CD8-Positive Cytotoxic T Lymphocytes Contribute to Human Papillomavirus Type 16 E6 and E7 Responses Clin. Vaccine Immunol., July 1, 1999; 6(4): 494 - 498. [Abstract] [Full Text] [PDF]